Key facts
- This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jun 2025, 18:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Bona Fide Gift. No compensation was given to the donor for the gifting of shares.